Ben Venue Recalls Vecuronium Bromide Injection Due to Particulate Matter
Ben Venue Laboratories is recalling Vecuronium Bromide for Injection due to the presence of particulate matter.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classification is FDA Class I, which mandates a minimum severity score of 4 according to the rubric.
Plain-English summary
Ben Venue Laboratories Inc is recalling 797 boxes of Vecuronium Bromide for Injection, 20 mg per vial (10 x 10 mg vials per carton). The product is identified by NDC 55390-039-10, Lot #2067134, with an expiration date of 5/31/2013.
The recall was initiated because of the presence of particulate matter in the product. The affected units were distributed nationwide.
Healthcare providers and patients should stop using the recalled product and contact Ben Venue Laboratories for further instructions.
The recalled product
- Product
- Vecuronium Bromide for Injection, For IV use only, 20 mg per vial, 10 x 10 mg Vials, lyophilized powder per carton, Rx Only, Mfr. By: Ben Venue Laboratories, Bedford, OH 44146: Mfg for: Bedford Labs, Bedford, OH 44146, NDC 55390-039-10.
- Manufacturer
- Ben Venue Laboratories Inc
- Category
- Drug — Injectable
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #2067134 Exp 5/31/2013
- NDC 55390-039-10
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · Ben Venue Laboratories Inc
See all →- SevereBen Venue Recalls Cytarabine for Injection Due to Sterility Concerns
FDA (Drugs) · 2014-08-27
- CriticalBen Venue Recalls Acetylcysteine Solution Due to Glass Particulate
FDA (Drugs) · 2014-05-28
- ModerateBen Venue Recalls Leucovorin Calcium Injection Due to Particulate Matter
FDA (Drugs) · 2012-11-07
- ModerateBen Venue Recalls Octreotide Acetate Injection Due to Potential Low Fill Volume
FDA (Drugs) · 2012-06-20
- ModerateBen Venue Recalls Midazolam HCl Injection Due to Potential Low Fill Volume
FDA (Drugs) · 2012-06-20
Same hazard · particulate matter
See all →- SevereACTHAR Gel Recalled for Presence of Glass and Stopper Particulate Matter
FDA (Drugs) · 2026-09-02
- SevereB. Braun Recalls Lactated Ringer's Injection Due to Particulate Matter
FDA (Drugs) · 2026-09-02
- SevereAmerican Regent Recalls Atropine Sulfate Injection Due to Particulate Matter
FDA (Drugs) · 2026-08-26
- SevereFDA Recalls Nicardipine Hydrochloride Injection Due to Particulate Matter
FDA (Drugs) · 2026-08-26
- SevereAmerican Regent Recalls Multrys Trace Elements Injection Due to Particulate Matter
FDA (Drugs) · 2026-08-26